Affimed N.V. (NASDAQ:AFMD) Q2 2024 Earnings Conference Call September 5, 2024 8:30 AM ET
Company Participants
Alex Fudukidis - Head, Investor Relations
Shawn Leland - Chief Executive Officer
Andreas Harstrick - Chief Medical Officer
Michael Wolf - Vice President, Finance
Conference Call Participants
Maury Raycroft - Jefferies
Daina Graybosch - Leerink Partners
Bill Jahangiri - Truist Securities
Li Watsek - Cantor
Brad Canino - Stifel
Swayampakula Ramakanth - H.C. Wainwright
Operator
Good day, everyone, and welcome to Affimed Second Quarter 2024 Earnings and Corporate Update Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, today's conference call is being recorded.
I would now like to introduce your host for today's call, Alex Fudukidis, Head of Investor Relations at Affimed. Please go ahead.
Alex Fudukidis
Thank you, Olivia, and thank you all for joining us today for our second quarter 2024 update call.
Before we begin, I'd like to remind everyone that we issued the relevant press release earlier today, and that can be found on our Investor Relations section of the website. On our website, you can also find the presentation we will be using today.
On the call today, we have members of our management team, including Shawn Leland, our new Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; Wolfgang Fischer, our Chief Operating Officer; Denise Mueller, our Chief Business Officer; and Harry Welten, our Consulting Chief Financial Officer. Our financials today will be presented by our VP of Finance, Michael Wolf. The team will be available for Q&A after the prepared remarks.
Before we start, I would like to remind you that today's presentation contains projections and forward-looking statements regarding future events. These statements represent our beliefs and assumptions only as of the date of this call. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements even if new information becomes available in the future.
These forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in these statements due to various factors, including, but not limited to, those identified under the section entitled Risk Factors in our filings with the SEC and those identified under the section entitled Forward-Looking Statements in the press release that we issued today and filed with the SEC.